RA'ANANA, Israel, Jan. 10, 2023 /PRNewswire/ -- Lydus Medical is pleased to announce that the Vesseal™ has received FDA clearance 510(k). The Vesseal™ is a microvascular anastomosis suture ...

FDA gives nod to Lydus Medical's microvascular anastomosis suture device. Jan. 12, 2023. By Doris Yu. No Comments. Lydus Medical Ltd. has obtained marketing approval from the U.S. FDA for its ...

A new review highlights the potential role of single nucleotide polymorphisms (SNPs) in improving the early diagnosis and targeted intervention of coronary microvascular dysfunction (CMD)—a ...

Microvascular ischemic disease is a term that’s used to describe changes to the small blood vessels in the brain. Changes to these vessels can damage white matter, the brain tissue that contains ...

RA'ANANA, Israel, Jan. 10, 2023 /PRNewswire/ -- Lydus Medical is pleased to announce that the Vesseal has received FDA clearance 510(k). The Vesseal is a microvascular anastomosis suture deployment ...

RA'ANANA, Israel, Jan. 9, 2023 /PRNewswire/ -- Lydus Medical is pleased to announce that the Vesseal™ has received FDA clearance 510(k). The Vesseal™ is a microvascular anastomosis suture ...

RA'ANANA, Israel, Jan. 10, 2023 /PRNewswire/ -- Lydus Medical is pleased to announce that the Vesseal™ has received FDA clearance 510(k). The Vesseal™ is a microvascular anastomosis suture ...